Objective:
To estimate the direct and indirect effects of the covid-19 pandemic on mortality in 2020 in 29 high income countries with reliable and complete age and sex disaggregated mortality data.
Design:
Time series study of high income countries.
Setting:
Austria, Belgium, Czech Republic, Denmark, England and Wales, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Latvia, Lithuania, the Netherlands, New Zealand, Northern Ireland, Norway, Poland, Portugal, Scotland, Slovakia, Slovenia, South Korea, Spain, Sweden, Switzerland, and United States.
Participants:
Mortality data from the Short-term Mortality Fluctuations data series of the Human Mortality Database for 2016-20, harmonised and disaggregated by age and sex.
Interventions:
Covid-19 pandemic and associated policy measures.
Main Outcome Measures:
Weekly excess deaths (observed deaths versus expected deaths predicted by model) in 2020, by sex and age (0-14, 15-64, 65-74, 75-84, and ≥85 years), estimated using an over-dispersed Poisson regression model that accounts for temporal trends and seasonal variability in mortality.
Results:
An estimated 979 000 (95% confidence interval 954 000 to 1 001 000) excess deaths occurred in 2020 in the 29 high income countries analysed. All countries had excess deaths in 2020, except New Zealand, Norway, and Denmark. The five countries with the highest absolute number of excess deaths were the US (458 000, 454 000 to 461 000), Italy (89 100, 87 500 to 90 700), England and Wales (85 400, 83 900 to 86 800), Spain (84 100, 82 800 to 85 300), and Poland (60 100, 58 800 to 61 300). New Zealand had lower overall mortality than expected (-2500, -2900 to -2100). In many countries, the estimated number of excess deaths substantially exceeded the number of reported deaths from covid-19. The highest excess death rates (per 100 000) in men were in Lithuania (285, 259 to 311), Poland (191, 184 to 197), Spain (179, 174 to 184), Hungary (174, 161 to 188), and Italy (168, 163 to 173); the highest rates in women were in Lithuania (210, 185 to 234), Spain (180, 175 to 185), Hungary (169, 156 to 182), Slovenia (158, 132 to 184), and Belgium (151, 141 to 162). Little evidence was found of subsequent compensatory reductions following excess mortality.
Conclusion:
Approximately one million excess deaths occurred in 2020 in these 29 high income countries. Age standardised excess death rates were higher in men than women in almost all countries. Excess deaths substantially exceeded reported deaths from covid-19 in many countries, indicating that determining the full impact of the pandemic on mortality requires assessment of excess deaths. Many countries had lower deaths than expected in children <15 years. Sex inequality in mortality widened further in most countries in 2020.
Citing Articles
Excess mortality and years of life lost from 2020 to 2023 in France: a cohort study of the overall impact of the COVID-19 pandemic on mortality.
Moulaire P, Hejblum G, Lapidus N
BMJ Public Health. 2025; 3(1):e001836.
PMID: 40051536
PMC: 11883889.
DOI: 10.1136/bmjph-2024-001836.
Excess Mortality in Türkiye during 2020-2022: Regional and Time-Based Analysis.
Keskin S, Ergor G
Balkan Med J. 2025; 42(2):130-137.
PMID: 40033635
PMC: 11883139.
DOI: 10.4274/balkanmedj.galenos.2025.2025-1-91.
Modest versus significant excess mortality due to COVID-19 deaths in Europe - authors' reply.
Pizzato M, Gerli A, La Vecchia C, Alicandro G
Lancet Reg Health Eur. 2025; 45:101061.
PMID: 39974772
PMC: 11838078.
DOI: 10.1016/j.lanepe.2024.101061.
Excess mortality during the first 2 years of the COVID-19 pandemic (2020-2021) in the Netherlands: Overall and across demographic subgroups.
Caram-Deelder C, van Hylckama Vlieg A, Groenwold R, Chen Q, Mook-Kanamori D, Dekkers O
IJID Reg. 2025; 14():100500.
PMID: 39830316
PMC: 11742297.
DOI: 10.1016/j.ijregi.2024.100500.
Indirect effects of the COVID-19 pandemic: A cause-of-death analysis of life expectancy changes in 24 countries, 2015 to 2022.
Polizzi A, Zhang L, Timonin S, Gupta A, Dowd J, Leon D
PNAS Nexus. 2024; 4(1):pgae508.
PMID: 39720204
PMC: 11664260.
DOI: 10.1093/pnasnexus/pgae508.
Patterns and drivers of excess mortality during the COVID-19 pandemic in 13 Western European countries.
Galmiche S, Coustaury C, Charniga K, Grant R, Cauchemez S, Fontanet A
BMC Glob Public Health. 2024; 2(1):78.
PMID: 39681939
PMC: 11626765.
DOI: 10.1186/s44263-024-00103-z.
Six-month outcomes after a GP phone call during the first French COVID-19 lockdown (COVIQuest): a cluster randomised trial using medico-administrative databases.
Sauvage A, Laurent E, Giraudeau B, Tassi M, Godillon L, Grammatico-Guillon L
BMJ Open. 2024; 14(11):e085094.
PMID: 39581719
PMC: 11590837.
DOI: 10.1136/bmjopen-2024-085094.
Active sport participation and walking before and during COVID-19 pandemic in a large cohort of Polish adults: results of the .
Szychowska A, Zimny-Zajac A, Dziankowska-Zaborszczyk E, Grodzicki T, Zdrojewski T, Gajda R
Int J Occup Med Environ Health. 2024; 37(4):468-481.
PMID: 39463141
PMC: 11627259.
DOI: 10.13075/ijomeh.1896.02430.
Estimating Excess Mortality During the COVID-19 Pandemic Between 2020-2022 in Korea.
Jang M, Kim S, Choi S, Ryu B, Choi S, Choi S
J Korean Med Sci. 2024; 39(40):e267.
PMID: 39435517
PMC: 11496562.
DOI: 10.3346/jkms.2024.39.e267.
Unraveling the impact of the COVID-19 pandemic on the mortality trends in Belgium between 2020-2022.
Natalia Y, Verbeeck J, Faes C, Neyens T, Molenberghs G
BMC Public Health. 2024; 24(1):2916.
PMID: 39434002
PMC: 11495090.
DOI: 10.1186/s12889-024-20415-x.
Impact of COVID-19 on total excess mortality and geographic disparities in Europe, 2020-2023: a spatio-temporal analysis.
Pizzato M, Gerli A, La Vecchia C, Alicandro G
Lancet Reg Health Eur. 2024; 44:100996.
PMID: 39410937
PMC: 11473197.
DOI: 10.1016/j.lanepe.2024.100996.
Thyroid Cancer Incidence During 2020 to 2021 COVID-19 Variant Waves.
Bell R, Weinberger D, Venkatesh M, Fernandes-Taylor S, Francis D, Davies L
JAMA Otolaryngol Head Neck Surg. 2024; .
PMID: 39388144
PMC: 11581733.
DOI: 10.1001/jamaoto.2024.3146.
Non-pharmaceutical interventions: evaluating challenges and priorities for future health shocks.
Majeed A, Quint J, Bhatt S, Davies F, Islam N
BMJ. 2024; 387:e080528.
PMID: 39374974
PMC: 11450877.
DOI: 10.1136/bmj-2024-080528.
Fatality from COVID-19 does not affect palliative care duration among patients with advanced cancer: a retrospective cohort study.
Jomar R, Marques J, De Oliveira L, Mendes G, Cunha D, Guimaraes R
Einstein (Sao Paulo). 2024; 22:eAO0536.
PMID: 39356939
PMC: 11461002.
DOI: 10.31744/einstein_journal/2024AO0536.
Cause-specific excess mortality in Denmark, Finland, Norway, and Sweden during the COVID-19 pandemic 2020-2022: a study using nationwide population data.
Nilsson A, Emilsson L, Kepp K, Knudsen A, Forthun I, Madsen C
Eur J Epidemiol. 2024; 39(9):1037-1050.
PMID: 39285102
PMC: 11470911.
DOI: 10.1007/s10654-024-01154-0.
Disentangling the relationship between cancer mortality and COVID-19 in the US.
Hansen C, Viboud C, Simonsen L
Elife. 2024; 13.
PMID: 39190600
PMC: 11349294.
DOI: 10.7554/eLife.93758.
Trends in diabetic ketoacidosis- and hyperosmolar hyperglycemic state-related mortality during the COVID-19 pandemic in the United States: A population-based study.
He X, Huang A, Lv F, Gao X, Guo Y, Liu Y
J Diabetes. 2024; 16(8):e13591.
PMID: 39136498
PMC: 11320749.
DOI: 10.1111/1753-0407.13591.
Examination of Gender Difference in Heart Disease-Related Excess Deaths during COVID-19 Pandemic Era: Findings from the United States.
Nguyen H, Jeon-Slaughter H
Rev Cardiovasc Med. 2024; 23(5):182.
PMID: 39077605
PMC: 11273782.
DOI: 10.31083/j.rcm2305182.
Regional inequalities in excess mortality and its community determinants during the early COVID-19 pandemic in South Korea.
Kim E, Lee W, Cho S
J Epidemiol Community Health. 2024; 78(10):654-660.
PMID: 38955462
PMC: 11420737.
DOI: 10.1136/jech-2023-221763.
Frontline health workers' experiences of providing care for people living with non-communicable diseases during the COVID-19 pandemic in Ghana: a qualitative study.
Baatiema L, de-Graft Aikins A, Koram K, Kunfah S, Allen L, Abimbola S
BMJ Open. 2024; 14(5):e078957.
PMID: 38719303
PMC: 11086292.
DOI: 10.1136/bmjopen-2023-078957.